0
2019
Japan Oncology Drugs Market

Japan Oncology Drugs Market

by Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy, and Hormonal Therapy), and Indication (Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Lung Cancer, Skin Cancer, Ovarian Cancer, Cervical Cancer, Kidney Cancer, and Other Cancers): Opportunity Analysis and Industry Forecast, 2019-2026

Report Code: A05277
Pages: 147
Aug 2019 | 6239 Views
Author(s) : Sagar M , Onkar S
Tables: 29
Charts: 56
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Japan Oncology Drugs Market

Request Now !

Japan Oncology Drugs Market Outlook - 2026

The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026. 

Cancer is a chronic medical condition that involves an abnormal growth of cells. The abnormal growth of cells results in the formation of a tumor. Furthermore, these abnormal tumor cells have the tendency to spread to other local tissues through blood and lymphatic system. Different types of cancers such as colorectal, stomach cancer and others are predominant among the Japanese populace. Treatment of cancer depends upon the stages of the disease progression. Chemotherapy is majorly used in the earlier stages whereas other therapy options such as targeted therapy drugs, immunological therapy drugs are used in late stage. 

Japan Oncology Drugs Market

Rise in incidence of cancer in Japan, surge in research related to new drug discovery for cancer treatment, and increase in healthcare expenditure are the major factors that fuel the growth of the Japan oncology drugs market. In addition, surge in awareness related to early diagnosis of cancer leading to rise in demand for oncology drugs for treatment boost the growth of the market in Japan. Furthermore, surge in geriatric population also contributes to the growth of the market as the elderly are more prone to certain cancers such as prostate cancer. In addition, rise in number of pipeline products is expected to provide lucrative opportunities during the forecast period. However, stringent approval process of oncology drugs in Japan hinders the growth of the market. 

Japan Oncology Drugs Market Segmentation  

The Japan oncology drugs market size is studied based on segment, drug class type, and indication. Based on drug class type, the market is divided into chemotherapy, targeted therapy, immunotherapy, hormonal therapy. By indication, it is categorized into blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, lung cancer, skin cancer, ovarian cancer, cervical cancer, kidney cancer, and others. 

Segment Review

Based on drug class type, the targeted therapy segment occupied the largest Japan oncology drugs market share in 2018 owing to lesser side effects of the drugs as compared to other treatment options. This is due to the ability of targeted therapies to kill only malignant cells thereby exhibiting better treatment outcomes. In addition, higher efficacy and higher survival rates associated with the use of targeted therapy drugs are other reasons that fuel the growth of the market. The immunotherapy segment is expected to show fastest growth during the forecast period owing to surge in incidence of cancer worldwide and high unmet medical needs in some countries. Moreover, immunotherapy drugs are widely accepted as an ideal treatment option as these drugs are potentially harmless to the other living cells of the body, which makes them less toxic as compared to other modes of cancer therapies. Furthermore, continuous efforts in R&D to design and develop new immunotherapeutic for the treatment of various cancer types serves as a key factor for the Japan oncology drugs market growth.

Japan Oncology Drugs Market By Drug Class Type

According to indication, the prostate cancer segment occupied the largest Japan oncology drugs market share in 2018. This is due to presence of huge geriatric population. The lung cancer segment is expected to experience fastest growth during the forecast period. This is due to technological developments in the field of cancer diagnostics and rise in the awareness related to the early diagnosis of cancer.

Japan Oncology Drugs Market By Indication

The Japan oncology drugs market is highly competitive and the prominent players in the market have adopted various strategies for garnering maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Otsuka Holdings Co Ltd, Johnson and Johnson, Daiichi Sankyo Co Ltd, AstraZeneca plc, AbbVie Inc., Celgene Corporation, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Astellas Pharma Inc., and Takeda Pharmaceutical Company Ltd

Key Benefits for Japan Oncology Drugs Market :

  • This report entails a detailed quantitative analysis along with the current Japan oncology drugs market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
  • The Japan oncology drugs market forecast is studied from 2019 to 2026. 
  • The market size and estimations are based on a comprehensive analysis of key developments in the Japan oncology drugs industry. 
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Japan Oncology Drugs Market Report Highlights

Aspects Details
By Drug Class Type
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy
By Indication
  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
    • B/Cholangiocarcinoma
    • Bladder cancer
    • Pancreatic cancer
  • Prostate Cancer
  • Lung Cancer
    • Small cell lung cancer
  • Skin Cancer
  • Ovarian Cancer
  • Cervical Cancer
  • Kidney cancer
  • Other cancers
Key Market Players ABBVIE INC., Astellas Pharma Inc., Johnson & Johnson (Janssen Pharmaceuticals, Inc.), Takeda Pharmaceutical Company Ltd., Daiichi Sankyo Company, Limited, Celgene Corporation, AstraZeneca plc, Hoffmann-La Roche AG, Otsuka Holdings Co., Ltd., Bristol-Myers Squibb Company
 

Loading Table Of Content...


 
 

Cancer is a large group of diseases that represent an abnormal growth of cells and tend to proliferate in an uncontrolled manner. Cancer is mostly named after the organ in which it initiates. For instance, lung cancer, breast cancer, colorectal, prostate cancer, and others. There are different treatments available for cancer such as chemotherapy, immunotherapy, and others. The management of cancer by the use of drugs is different in every patient as the treatment depends on the tumor progression.

The key factor responsible for the growth of the Japan oncology drugs market is increase in prevalence of cancer. Furthermore, the market growth is also propelled by surge in geriatric population, increase in collaboration between pharmaceutical companies for development of novel cancer drugs, and rise in awareness associated with early detection of cancer among populace. In addition, surge in geriatric population also contributes to the growth of the market as the elderly are more prone to certain cancers such as prostate cancer.

Moreover, rise in number of pipeline products is expected to provide lucrative opportunities during the forecast period. However, stringent approval process of oncology drugs in Japan hinders the growth of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Japan Oncology Drugs Market

Start reading instantly.
This Report and over 53,643+ more Reports, Available with Avenue Library. T&C*.

  • Data Pack
  • $1,845
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2020 - Aug 2021)
  • Single User
  • $2,580
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2020 - Aug 2021)
  • Five Users
  • $3,099
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2020 - Aug 2021)
  • Enterprise
    License/PDF

  • $5,322
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2020 - Aug 2021)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers